source
- Arvinas’ ‘Protac’ breast cancer drug cleared by FDAKnown as Veppanu, the drug is the first of its kind to get to market. But Arvinas and partner Pfizer are still searching for a new partner to sell it.BioPharma Dive · 3mo ago↗ source
- Summit’s ‘self-inflicted’ stumble; Esperion’s take-private dealSummit’s decision to conduct an interim analysis of a closely watched trial backfired. Elsewhere, Axsome got a much-needed label expansion and an FDA committee sided against an AstraZeneca breast c…BioPharma Dive · 3mo ago↗ source
- Moderna sees revenue bump from international COVID vaccine salesThe company is making up for a decline in U.S. vaccine sales with better results elsewhere, continuing a turnaround that’s vaulted its stock price in 2026.